Suppr超能文献

原发性甲状腺B细胞淋巴瘤:对其克隆进化和复发的分子见解

Primary thyroid B-cell lymphoma: molecular insights into its clonal evolution and relapse.

作者信息

Tzioni Maria-Myrsini, Watanabe Natsuko, Chen Zi, Wu Fangtian, Madej Ewelina, Makker Jasmine, Guo Sarah, Attygalle Ayoma D, Wotherspoon Andrew, Sugino Kiminori, Ito Koichi, Du Ming-Qing

机构信息

Department of Pathology, University of Cambridge, Cambridge, UK.

Department of Internal Medicine, Ito Hospital, Tokyo, Japan.

出版信息

J Pathol. 2025 Feb;265(2):123-131. doi: 10.1002/path.6380. Epub 2024 Dec 26.

Abstract

Primary thyroid lymphomas comprise largely extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL) and diffuse large B-cell lymphoma (DLBCL), followed by follicular lymphoma (FL). They commonly develop from a background of Hashimoto's thyroiditis (HT), where dysregulated immune responses trigger autoreactive infiltrates and drive clonal B-cell evolution. To understand how these lymphomas and their relapse evolve, we investigated 10 cases by mutation profiling, including five with metachronous lymphomas [primary lymphoma (EMZL = 4, DLBCL = 1) with local relapse (EMZL = 3, DLBCL = 2)], one composite EMZL and Epstein-Barr virus (EBV)-positive DLBCL, and four lymphomas (EMZL = 3, FL = 1) with prior or subsequent biopsy showing HT. In four cases with metachronous lymphomas, both common and distinct variants were seen in the paired lesions, indicating their divergent evolution from clonally related lymphoma precursor (CLP) cells. In the remaining case with metachronous lymphomas, the relapsed lesion was progressed from the initial lymphoma. In the case with composite lymphoma, the EBV-positive DLBCL was transformed from EMZL. Finally, in the four cases with paired lymphoma and HT biopsies, two showed shared mutations between the paired lesions, indicating involvement and divergent evolution from CLP cells. Thyroid lymphoma relapse may frequently develop via divergent evolution from a CLP cell, which is likely premalignant. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

摘要

原发性甲状腺淋巴瘤主要包括黏膜相关淋巴组织结外边缘区淋巴瘤(EMZL)和弥漫性大B细胞淋巴瘤(DLBCL),其次是滤泡性淋巴瘤(FL)。它们通常在桥本甲状腺炎(HT)的背景下发生,免疫反应失调会引发自身反应性浸润,并推动克隆性B细胞进化。为了解这些淋巴瘤及其复发是如何演变的,我们通过突变谱分析对10例病例进行了研究,其中包括5例异时性淋巴瘤[原发性淋巴瘤(EMZL = 4,DLBCL = 1)伴局部复发(EMZL = 3,DLBCL = 2)]、1例复合性EMZL和爱泼斯坦 - 巴尔病毒(EBV)阳性DLBCL,以及4例先前或随后活检显示为HT的淋巴瘤(EMZL = 3,FL = 1)。在4例异时性淋巴瘤病例中,配对病变中可见共同和不同的变异,表明它们从克隆相关的淋巴瘤前体细胞(CLP)发生了不同的演变。在其余1例异时性淋巴瘤病例中,复发病变是从初始淋巴瘤进展而来。在复合性淋巴瘤病例中,EBV阳性DLBCL是由EMZL转化而来。最后,在4例配对的淋巴瘤和HT活检病例中,2例在配对病变之间显示出共同突变,表明CLP细胞参与其中并发生了不同的演变。甲状腺淋巴瘤复发可能经常通过从可能是癌前的CLP细胞的不同演变而发生。© 2024作者。《病理学杂志》由约翰·威利父子有限公司代表大不列颠及爱尔兰病理学会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637d/11717488/f0d53f32fcca/PATH-265-123-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验